KATHERINE BOURNE: Open Payments
NPI 1235823279 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 50 payments from 13 companies in 2025. Trend: 2023 $147 · 2024 $856 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $283 |
| Novo Nordisk Inc | 5 | $93 |
| GlaxoSmithKline, LLC. | 6 | $92 |
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
| Lilly USA, LLC | 4 | $61 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $26 |
| Dexcom, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Tonix Medicines, Inc. | 1 | $17 |
Products named: VRAYLAR, TRELEGY ELLIPTA, UBRELVY, Ozempic, FARXIGA, VIBERZI, MOUNJARO, QULIPTA.
Industry payments across TN — which companies pay providers there.
